Malignant epithelioid angiomyolipoma: tumor and metabolic response to everolimus as evaluated with positron emission tomography

Clin Genitourin Cancer. 2013 Dec;11(4):e1-5. doi: 10.1016/j.clgc.2013.04.032. Epub 2013 Jun 20.
No abstract available

Keywords: Angiomyolipoma; Imaging; Kidney tumors; Lymphoma; Mammalian target of rapamycin.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Angiomyolipoma / diagnostic imaging*
  • Angiomyolipoma / drug therapy*
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Everolimus
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Neoplasms / diagnostic imaging
  • Kidney Neoplasms / drug therapy
  • Lymphoma, T-Cell* / complications
  • Lymphoma, T-Cell* / drug therapy
  • Lymphoma, T-Cell* / mortality
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Prednisone / therapeutic use
  • Radiography
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use
  • Vincristine / therapeutic use

Substances

  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Everolimus
  • Prednisone
  • Sirolimus

Supplementary concepts

  • CHOP protocol